Nausea rates in retatrutide trials reached approximately 45% at the maximum dose, compared to roughly 31% for tirzepatide
Peripheral neuropathy, burning or tingling nerve pain, chronic inflammation, diabetes-related nerve issues
This is a big motivator in helping me move more and make better food decisions
People still need comprehensive care in order to accomplish the goals they and doctors like us want: significant weight loss, improved health, disease prevention
At each step in the shared decision-making process, clinicians need to identify a motivation for the patient to lose weight, according to Barbara Eichorst, MS, RD, CDCES, vice president of health care programs at the American Diabetes Association
Ozempic is typically covered by insurance for type 2 diabetes treatment